The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
Tislelizumab is now approved in nine indications in China
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
A big boost to healthcare efforts of Ayush through NARIP, CCRAS
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
If approved, Tafinlar + Mekinist may offer a potential new standard-of-care for pediatric patients with this brain cancer
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
The rally attracted around 250 riders, including professionals and amateurs.
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Subscribe To Our Newsletter & Stay Updated
